Cargando…

Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform

Real-world data sources, including electronic health records (EHRs) and personal digital device data, are increasingly available, but are often siloed and cannot be easily integrated for clinical, research, or regulatory purposes. We conducted a prospective cohort study of 60 patients undergoing bar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhruva, Sanket S., Ross, Joseph S., Akar, Joseph G., Caldwell, Brittany, Childers, Karla, Chow, Wing, Ciaccio, Laura, Coplan, Paul, Dong, Jun, Dykhoff, Hayley J., Johnston, Stephen, Kellogg, Todd, Long, Cynthia, Noseworthy, Peter A., Roberts, Kurt, Saha, Anindita, Yoo, Andrew, Shah, Nilay D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170944/ https://www.ncbi.nlm.nih.gov/pubmed/32352038 http://dx.doi.org/10.1038/s41746-020-0265-z

Ejemplares similares

Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices
por: Bartlett, Victoria L., et al.
Publicado: (2021)

Feasibility of using real-world data in the evaluation of cardiac ablation catheters: a test-case of the National Evaluation System for Health Technology Coordinating Center
por: Dhruva, Sanket S, et al.
Publicado: (2021)

Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence
por: Bartlett, Victoria L., et al.
Publicado: (2019)

Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation
por: Yu, Yue, et al.
Publicado: (2023)

Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: A fit-for-purpose informatics analysis report
por: Jiang, Guoqian, et al.
Publicado: (2021)

Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology
por: Akar, Joseph G, et al.
Publicado: (2020)

Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10‐Year Assessment
por: DuBose‐Briski, Victoria, et al.
Publicado: (2019)

Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
por: Deng, Yihong, et al.
Publicado: (2022)

Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
por: Liu, Patrick, et al.
Publicado: (2021)

Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval
por: Wallach, Joshua D., et al.
Publicado: (2021)

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
por: Bartlett, Victoria L., et al.
Publicado: (2020)

Heart Watch Study: protocol for a pragmatic randomised controlled trial
por: Dhruva, Sanket S, et al.
Publicado: (2021)

Safety and Effectiveness of a Catheter With Contact Force and 6-Hole Irrigation for Ablation of Persistent Atrial Fibrillation in Routine Clinical Practice
por: Dhruva, Sanket S., et al.
Publicado: (2022)

Age of Data at the Time of Publication of Contemporary Clinical Trials
por: Welsh, John, et al.
Publicado: (2018)

Evidence supporting FDA approval and CMS national coverage determinations for novel medical products, 2005 through 2016: A cross-sectional study
por: Roginiel, Aliya C., et al.
Publicado: (2018)

Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
por: Shaw, Daniel L., et al.
Publicado: (2018)

Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study
por: Mooghali, Maryam, et al.
Publicado: (2023)

GLASS(Y) Half-Full: Moving Towards Greater Pragmatism in Outcome Ascertainment for Clinical Trials
por: Dhruva, Sanket S.
Publicado: (2021)

Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
por: Wallach, Joshua D., et al.
Publicado: (2021)

Patient-reported outcomes and medical device evaluation: from conception to implementation
por: Webber, Christina M., et al.
Publicado: (2022)

Use of Mechanical Cardiopulmonary Resuscitation Devices for Out-of-Hospital Cardiac Arrest, 2010-2016
por: Kahn, Peter A., et al.
Publicado: (2019)

Overview and experience of the YODA Project with clinical trial data sharing after 5 years
por: Ross, Joseph S., et al.
Publicado: (2018)

Exploring unique device identifier implementation and use for real-world evidence: a mixed-methods study with NESTcc health system network collaborators
por: Dhruva, Sanket S., et al.
Publicado: (2023)

Medical device risk (re)classification: lessons from the FDA’s 515 Program Initiative
por: Mooghali, Maryam, et al.
Publicado: (2023)

Aggregating labels in crowdsourcing Data
por: Ms. PRIISALU, Maria
Publicado: (2015)

The CMS Data Aggregation System
por: Kuznetsov, Valentin, et al.
Publicado: (2010)

Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
por: Wallach, Joshua D., et al.
Publicado: (2019)

Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
por: Skydel, Joshua J., et al.
Publicado: (2019)

Data-Driven and Multiscale Modeling of DNA-Templated Dye Aggregates
por: Biaggne, Austin, et al.
Publicado: (2022)

Medical Device Regulation: Time to Improve Performance
por: Dhruva, Sanket S., et al.
Publicado: (2012)

Accurate estimation of cardiovascular risk in a non-diabetic adult: detecting and correcting the error in the reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial population
por: Warner, Frederick, et al.
Publicado: (2018)

Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study
por: Peterson, Madeline N., et al.
Publicado: (2021)

Rethinking Data Sharing at the Dawn of a Health Data Economy: A Viewpoint
por: Tang, Chunlei, et al.
Publicado: (2018)

Do patient-reported outcome measures measure up? A qualitative study to examine perceptions and experiences with heart failure proms among diverse, low-income patients
por: Davis, Jonathan, et al.
Publicado: (2022)

Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data
por: Dhruva, Sanket S., et al.
Publicado: (2020)

Accrued – An R Package for Visualizing Data Quality for Aggregate Surveillance Data
por: Eaton, Julie, et al.
Publicado: (2014)

Feasibility of Homomorphic Encryption for Sharing I2B2 Aggregate-Level Data in the Cloud
por: Raisaro, Jean Louis, et al.
Publicado: (2018)

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020
por: Essa, Mohammed, et al.
Publicado: (2023)

Topological Data Analysis of Biological Aggregation Models
por: Topaz, Chad M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ghmdaov4ao6isac14s2hqbebha